GSK Sells $1.1 Billion Stake in Former Consumer Unit Haleon
- UK drug group sells latest batch of shares in maker of Panadol
- GSK still holds a 7.4% stake in Haleon following the sale
This article is for subscribers only.
GSK Plc has raised £886 million ($1.1 billion) from the latest sale of a tranche of shares in Haleon Plc, the consumer-health business it spun off last year.
The British drug company sold 270 million shares at a price of 328 pence, according to a regulatory announcement Friday. The price reflects a discount of about 2.5% to Haleon’s closing price on Thursday.